A very well-designed study recently provided evidence not only of the association between obesity and an increase in intestinal IDO activity but also that genetic IDO deletion reduced endotoxemia and inflammation (98). Here, IDO1 is linked to obesity due to melanocortin 4 receptor deficiency.